Cargando…
The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors
BACKGROUND: Inflammation is considered essential in cancer progression, as it affects the nutritional status and prognosis of patients. In this study, we aim to analyze the efficacy of various inflammatory markers in predicting prognosis in cancer patients. METHODS: Patients with malignant tumor wer...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573157/ https://www.ncbi.nlm.nih.gov/pubmed/34764670 http://dx.doi.org/10.2147/JIR.S334941 |
_version_ | 1784595361922285568 |
---|---|
author | Zheng, Kaiwen Liu, Xiangliang Ji, Wei Lu, Jin Cui, Jiuwei Li, Wei |
author_facet | Zheng, Kaiwen Liu, Xiangliang Ji, Wei Lu, Jin Cui, Jiuwei Li, Wei |
author_sort | Zheng, Kaiwen |
collection | PubMed |
description | BACKGROUND: Inflammation is considered essential in cancer progression, as it affects the nutritional status and prognosis of patients. In this study, we aim to analyze the efficacy of various inflammatory markers in predicting prognosis in cancer patients. METHODS: Patients with malignant tumor were included as primary and validation cohort. Basic clinical information, anthropometric indicators, body composition analysis, and serological indicators were recorded. After proposing the optimal thresholds by time-dependent receiver operating characteristic (ROC), univariate and multivariate Cox regression analyses were performed to analyze the association between inflammatory markers and overall survival (OS). A nomogram was established to develop a scored-inflammatory marker system. Eight inflammatory models based on combinations of inflammatory markers were assessed. Cox regression analysis was used to analyze the relationship of each inflammatory model and mortality of participants. Then, subanalysis of specific tumor types was conducted by Cox regression. Logistic regression models were used to analyze the relationship between different inflammatory models and malnutrition. RESULTS: Univariate and multivariate Cox regression analyses indicated that pack-years of cigarette smoking, C-reactive protein (CRP), and systemic immune-inflammation index (SII) were related to the OS of cancer patients. A nomogram was constructed to develop a scored-inflammatory marker system. Among the eight inflammatory models, patients in model A had worst prognosis compared with patients in other models. Subanalysis next showed lung cancer, breast cancer and digestive system neoplasms patients in model A suffered the worst prognosis. Logistic regression indicated that model A was also with predictive value for malnutrition. CONCLUSION: A scored-inflammatory marker system was established to predict the OS of cancer patients. The inflammatory models established in this study can be used to predict prognosis, as well as cancer-related malnutrition. Inflammatory model A suffered the worst OS and was with the predictive efficacy for malnutrition. |
format | Online Article Text |
id | pubmed-8573157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-85731572021-11-10 The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors Zheng, Kaiwen Liu, Xiangliang Ji, Wei Lu, Jin Cui, Jiuwei Li, Wei J Inflamm Res Original Research BACKGROUND: Inflammation is considered essential in cancer progression, as it affects the nutritional status and prognosis of patients. In this study, we aim to analyze the efficacy of various inflammatory markers in predicting prognosis in cancer patients. METHODS: Patients with malignant tumor were included as primary and validation cohort. Basic clinical information, anthropometric indicators, body composition analysis, and serological indicators were recorded. After proposing the optimal thresholds by time-dependent receiver operating characteristic (ROC), univariate and multivariate Cox regression analyses were performed to analyze the association between inflammatory markers and overall survival (OS). A nomogram was established to develop a scored-inflammatory marker system. Eight inflammatory models based on combinations of inflammatory markers were assessed. Cox regression analysis was used to analyze the relationship of each inflammatory model and mortality of participants. Then, subanalysis of specific tumor types was conducted by Cox regression. Logistic regression models were used to analyze the relationship between different inflammatory models and malnutrition. RESULTS: Univariate and multivariate Cox regression analyses indicated that pack-years of cigarette smoking, C-reactive protein (CRP), and systemic immune-inflammation index (SII) were related to the OS of cancer patients. A nomogram was constructed to develop a scored-inflammatory marker system. Among the eight inflammatory models, patients in model A had worst prognosis compared with patients in other models. Subanalysis next showed lung cancer, breast cancer and digestive system neoplasms patients in model A suffered the worst prognosis. Logistic regression indicated that model A was also with predictive value for malnutrition. CONCLUSION: A scored-inflammatory marker system was established to predict the OS of cancer patients. The inflammatory models established in this study can be used to predict prognosis, as well as cancer-related malnutrition. Inflammatory model A suffered the worst OS and was with the predictive efficacy for malnutrition. Dove 2021-11-03 /pmc/articles/PMC8573157/ /pubmed/34764670 http://dx.doi.org/10.2147/JIR.S334941 Text en © 2021 Zheng et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zheng, Kaiwen Liu, Xiangliang Ji, Wei Lu, Jin Cui, Jiuwei Li, Wei The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors |
title | The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors |
title_full | The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors |
title_fullStr | The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors |
title_full_unstemmed | The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors |
title_short | The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors |
title_sort | efficacy of different inflammatory markers for the prognosis of patients with malignant tumors |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573157/ https://www.ncbi.nlm.nih.gov/pubmed/34764670 http://dx.doi.org/10.2147/JIR.S334941 |
work_keys_str_mv | AT zhengkaiwen theefficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors AT liuxiangliang theefficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors AT jiwei theefficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors AT lujin theefficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors AT cuijiuwei theefficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors AT liwei theefficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors AT zhengkaiwen efficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors AT liuxiangliang efficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors AT jiwei efficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors AT lujin efficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors AT cuijiuwei efficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors AT liwei efficacyofdifferentinflammatorymarkersfortheprognosisofpatientswithmalignanttumors |